Skip to main content

Table 2 The mRNA level of ARHGAP11A correlated to clinicopathological variables in TCGA

From: Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma

Clinicopathological variables ARHGAP11A mRNA expression Total P value
Low High
Clinical grades
 G1/2 137 95 232 .000
 G3/4 47 87 134
Total 184 182 366  
T Stage
 T1 106 75 181 .001
 T2 41 53 94
 T3/4 36 57 93
Total 183 185 368  
Pathological Stage
 Stage I 99 72 171 .004
 Stage II 39 47 86
 Stage III/IV 36 54 90
Total 174 173 347